Historical Stock Price
ETFs Holding NAVB »    NAVB Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
04/14/2021 $1.67 $1.75 $1.66 $1.67 127.20K
04/15/2021 $1.66 $1.75 $1.65 $1.67 85.50K
04/16/2021 $1.73 $1.73 $1.60 $1.64 152.90K
04/19/2021 $1.60 $1.62 $1.55 $1.57 117.40K
04/20/2021 $1.52 $1.59 $1.51 $1.55 89.60K
Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform and NAV4694; and therapeutic development programs, including therapeutic applications of its Manocept platform.
NAVB historical stock prices picture
Navidea Biopharmaceuticals (NAVB) has the following price history information. Looking back at NAVB historical stock prices for the last five trading days, on April 14, 2021, NAVB opened at $1.67, traded as high as $1.75 and as low as $1.66, and closed at $1.67. Trading volume was a total of 127.20K shares. On April 15, 2021, NAVB opened at $1.66, traded as high as $1.75 and as low as $1.65, and closed at $1.67. Trading volume was a total of 85.50K shares. On April 16, 2021, NAVB opened at $1.73, traded as high as $1.73 and as low as $1.60, and closed at $1.64. Trading volume was a total of 152.90K shares. On April 19, 2021, NAVB opened at $1.60, traded as high as $1.62 and as low as $1.55, and closed at $1.57. Trading volume was a total of 117.40K shares. On April 20, 2021, NAVB opened at $1.52, traded as high as $1.59 and as low as $1.51, and closed at $1.55. Trading volume was a total of 89.60K shares.

NAVB Historical Stock Prices By Date:

NAVB historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Navidea Biopharmaceuticals shares, starting with a $10,000 purchase of NAVB, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/21/2011
End date: 04/20/2021
Start price/share: $90.60
End price/share: $1.55
Dividends collected/share: $0.00
Total return: -98.29%
Average Annual Total Return: -33.41%
Starting investment: $10,000.00
Ending investment: $171.05
Years: 10.01
Date Close
04/14/2021$1.67
04/15/2021$1.67
04/16/2021$1.64
04/19/2021$1.57
04/20/2021$1.55
NAVB is categorized under the Healthcare sector; below are some other companies in the same sector:

NBIX Historical Stock Prices
NBS Historical Stock Prices
NBY Historical Stock Prices
NDRA Historical Stock Prices
NDZ Historical Stock Prices
NEO Historical Stock Prices
NEOG Historical Stock Prices
NEOS Historical Stock Prices
NEOT Historical Stock Prices
NERV Historical Stock Prices

NAVB Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.